FindTrial
Sign In

A scientific experiment to study the effects of the drug Ropivacaine with two additives, Clonidine and Dexmedetomidine, instilled inside abdomen in patients undergoing elective laparoscopic cholecystectomy

A prospective randomized double blind control study comparing the analgesic efficacy of intraperitoneal Ropivacaine with Dexmedetomidine and Ropivacaine with Clonidine in patients undergoing elective laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047103
Enrollment
90
Registered
2022-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Group RC: Intraperitoneal instillation of 40ml 0.25% Ropivacaine plus 1mcg/kg Clonidine in 5ml NS Intervention2: Group RD: Intraperitoneal instillation of 40ml 0.25% Ropivacaine plus 1m

Sponsors

Department of Anesthesiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All ASA grade I and grade II patients between 19-60 years age group

Exclusion criteria

Exclusion criteria: · All ASA grade III and IV patients. · Diabetes and Hypertension. · Cardiovascular, respiratory and neurological disorders. · Obesity (BMI >30kg/m2). · Drug allergy

Design outcomes

Primary

MeasureTime frame
Numerical Rating Score (NRS) Time for first request of analgesiaTimepoint: 24 hours—

Secondary

MeasureTime frame
Adverse effectsTimepoint: 24 hours;Patient satisfactionTimepoint: 48 hours—

Countries

India

Contacts

Public ContactPriyadarshini Kalahasthi

Mysore Medical College and Research Institute

drshi72@gmail.com9148650639

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026